Mainstay Group of Funds > MAINSTAY FUNDS TRUST
MainStay WMC Small Companies Fund
$300.37M
Avg Monthly Net Assets
$316.38M
Total Assets
$595K
Total Liabilities
$315.79M
Net Assets
MainStay WMC Small Companies Fund is a Mutual Fund in MAINSTAY FUNDS TRUST
from Mainstay Group of Funds,
based in New York,
United States of America.
The fund has eight share classes
and monthly net assets of $300.37M.
On September 23rd, 2024 it reported 140 holdings, the largest
being iShares Russell 2000 ETF (3.6%), MRC Global, Inc. (2.4%) and Magnite, Inc. (2.2%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A | C000112270 | MOPAX | |
| Class B | C000112266 | MOTBX | |
| Class C | C000112267 | MOPCX | |
| Class I | C000112268 | MOPIX | |
| Class R1 | C000118993 | MOPRX | |
| Class R2 | C000118994 | MOTRX | |
| Class R3 | C000166845 | MOVRX | |
| Investor Class | C000112269 | MOINX |
Holdings
From latest NPORT-P, filed September 23rd, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Long | Equity-common | US | $125K | 7K | 0.04 |
| ACADIA Pharmaceuticals, Inc. | Long | Equity-common | US | $362K | 19K | 0.11 |
| ADMA Biologics, Inc. | Long | Equity-common | US | $439K | 36K | 0.14 |
| Agilysys, Inc. | Long | Equity-common | US | $6M | 50K | 1.79 |
| Agios Pharmaceuticals, Inc. | Long | Equity-common | US | $417K | 9K | 0.13 |
| Akero Therapeutics, Inc. | Long | Equity-common | US | $285K | 11K | 0.09 |
| Alkermes plc | Long | Equity-common | IE | $757K | 28K | 0.24 |
| Amicus Therapeutics, Inc. | Long | Equity-common | US | $495K | 48K | 0.16 |
| Amneal Pharmaceuticals, Inc. | Long | Equity-common | US | $187K | 25K | 0.06 |
| Amphastar Pharmaceuticals, Inc. | Long | Equity-common | US | $267K | 6K | 0.08 |
| ANI Pharmaceuticals, Inc. | Long | Equity-common | US | $195K | 3K | 0.06 |
| Apogee Therapeutics, Inc. | Long | Equity-common | US | $263K | 5K | 0.08 |
| Arcellx, Inc. | Long | Equity-common | US | $426K | 7K | 0.13 |
| Arcutis Biotherapeutics, Inc. | Long | Equity-common | US | $162K | 16K | 0.05 |
| Ardelyx, Inc. | Long | Equity-common | US | $202K | 36K | 0.06 |
| Arrowhead Pharmaceuticals, Inc. | Long | Equity-common | US | $547K | 19K | 0.17 |
| Artivion, Inc. | Long | Equity-common | US | $6M | 219K | 1.88 |
| Arvinas, Inc. | Long | Equity-common | US | $263K | 10K | 0.08 |
| Avadel Pharmaceuticals plc | Long | Equity-common | IE | $244K | 15K | 0.08 |
| Avidity Biosciences, Inc. | Long | Equity-common | US | $742K | 16K | 0.24 |
| Axsome Therapeutics, Inc. | Long | Equity-common | US | $525K | 6K | 0.17 |
| Banner Corp. | Long | Equity-common | US | $4M | 64K | 1.20 |
| Beam Therapeutics, Inc. | Long | Equity-common | US | $364K | 12K | 0.12 |
| BioCryst Pharmaceuticals, Inc. | Long | Equity-common | US | $232K | 32K | 0.07 |
| Biohaven Ltd. | Long | Equity-common | VG | $468K | 12K | 0.15 |
| Blue Bird Corp. | Long | Equity-common | US | $7M | 130K | 2.15 |
| Blueprint Medicines Corp. | Long | Equity-common | US | $1M | 10K | 0.35 |
| Brady Corp., Class A | Long | Equity-common | US | $6M | 80K | 1.82 |
| Bridgebio Pharma, Inc. | Long | Equity-common | US | $594K | 23K | 0.19 |
| BWX Technologies, Inc. | Long | Equity-common | US | $5M | 46K | 1.44 |
| CareTrust REIT, Inc. | Long | Equity-common | US | $5M | 202K | 1.73 |
| Catalyst Pharmaceuticals, Inc. | Long | Equity-common | US | $311K | 18K | 0.10 |
| Celldex Therapeutics, Inc. | Long | Equity-common | US | $388K | 10K | 0.12 |
| Civitas Resources, Inc. | Long | Equity-common | US | $4M | 58K | 1.29 |
| Collegium Pharmaceutical, Inc. | Long | Equity-common | US | $207K | 5K | 0.07 |
| Corcept Therapeutics, Inc. | Long | Equity-common | US | $503K | 13K | 0.16 |
| Crinetics Pharmaceuticals, Inc. | Long | Equity-common | US | $658K | 12K | 0.21 |
| Cytokinetics, Inc. | Long | Equity-common | US | $1M | 18K | 0.34 |
| Dana, Inc. | Long | Equity-common | US | $2M | 165K | 0.67 |
| Denali Therapeutics, Inc. | Long | Equity-common | US | $473K | 19K | 0.15 |
| Dynavax Technologies Corp. | Long | Equity-common | US | $243K | 22K | 0.08 |
| Dyne Therapeutics, Inc. | Long | Equity-common | US | $554K | 13K | 0.18 |
| Edgewise Therapeutics, Inc. | Long | Equity-common | US | $201K | 12K | 0.06 |
| Enova International, Inc. | Long | Equity-common | US | $7M | 77K | 2.10 |
| Federal Agricultural Mortgage Corp., Class C | Long | Equity-common | US | $5M | 22K | 1.45 |
| Freshpet, Inc. | Long | Equity-common | US | $6M | 51K | 1.95 |
| Geron Corp. | Long | Equity-common | US | $458K | 97K | 0.14 |
| Goodyear Tire & Rubber Co. (The) | Long | Equity-common | US | $4M | 377K | 1.40 |
| Greenbrier Cos., Inc. (The) | Long | Equity-common | US | $5M | 101K | 1.63 |
| Greif, Inc., Class A | Long | Equity-common | US | $5M | 68K | 1.43 |
| Halozyme Therapeutics, Inc. | Long | Equity-common | US | $1M | 21K | 0.36 |
| Harmony Biosciences Holdings, Inc. | Long | Equity-common | US | $171K | 5K | 0.05 |
| Helix Energy Solutions Group, Inc. | Long | Equity-common | US | $4M | 354K | 1.32 |
| Hilton Grand Vacations, Inc. | Long | Equity-common | US | $5M | 117K | 1.60 |
| Hims & Hers Health, Inc. | Long | Equity-common | US | $7M | 313K | 2.10 |
| Ideaya Biosciences, Inc. | Long | Equity-common | US | $504K | 12K | 0.16 |
| ImmunityBio, Inc. | Long | Equity-common | US | $119K | 23K | 0.04 |
| Immunovant, Inc. | Long | Equity-common | US | $281K | 10K | 0.09 |
| Independence Realty Trust, Inc. | Long | Equity-common | US | $4M | 236K | 1.40 |
| Infinera Corp. | Long | Equity-common | US | $5M | 783K | 1.47 |
| Insmed, Inc. | Long | Equity-common | US | $2M | 25K | 0.57 |
| Intellia Therapeutics, Inc. | Long | Equity-common | US | $376K | 14K | 0.12 |
| Interface, Inc. | Long | Equity-common | US | $7M | 384K | 2.10 |
| INVESCO GOVERNMENT & AGENCY PORTFOLIO OPEN-END FUND USD (INVESCO GOVT AND AGCY LEX) | Long | Short-term investment vehicle | US | $251K | 251K | 0.08 |
| Iovance Biotherapeutics, Inc. | Long | Equity-common | US | $330K | 38K | 0.10 |
| iShares Russell 2000 ETF | Long | Exchange traded fund | US | $12M | 51K | 3.64 |
| Janux Therapeutics, Inc. | Long | Equity-common | US | $185K | 5K | 0.06 |
| Keros Therapeutics, Inc. | Long | Equity-common | US | $224K | 4K | 0.07 |
| Krystal Biotech, Inc. | Long | Equity-common | US | $824K | 4K | 0.26 |
| Kura Oncology, Inc. | Long | Equity-common | US | $231K | 11K | 0.07 |
| Kymera Therapeutics, Inc. | Long | Equity-common | US | $307K | 7K | 0.10 |
| Laureate Education, Inc. | Long | Equity-common | US | $5M | 331K | 1.63 |
| Ligand Pharmaceuticals, Inc. | Long | Equity-common | US | $300K | 3K | 0.09 |
| Longboard Pharmaceuticals, Inc. | Long | Equity-common | US | $184K | 6K | 0.06 |
| Macerich Co. (The) | Long | Equity-common | US | $5M | 311K | 1.58 |
| Madrigal Pharmaceuticals, Inc. | Long | Equity-common | US | $809K | 3K | 0.26 |
| Magnite, Inc. | Long | Equity-common | US | $7M | 475K | 2.19 |
| MainStay U.S. Government Liquidity Fund, Class I | Long | Short-term investment vehicle | US | $1M | 1M | 0.35 |
| MannKind Corp. | Long | Equity-common | US | $247K | 43K | 0.08 |
| Marcus & Millichap, Inc. | Long | Equity-common | US | $4M | 109K | 1.37 |
| Marten Transport Ltd. | Long | Equity-common | US | $3M | 179K | 1.07 |
| Maximus, Inc. | Long | Equity-common | US | $5M | 52K | 1.53 |
| Minerals Technologies, Inc. | Long | Equity-common | US | $5M | 69K | 1.70 |
| Mirum Pharmaceuticals, Inc. | Long | Equity-common | US | $248K | 6K | 0.08 |
| Morphic Holding, Inc. | Long | Equity-common | US | $376K | 7K | 0.12 |
| MRC Global, Inc. | Long | Equity-common | US | $8M | 528K | 2.42 |
| Myriad Genetics, Inc. | Long | Equity-common | US | $400K | 14K | 0.13 |
| New Jersey Resources Corp. | Long | Equity-common | US | $5M | 103K | 1.52 |
| NMI Holdings, Inc., Class A | Long | Equity-common | US | $5M | 125K | 1.55 |
| Novavax, Inc. | Long | Equity-common | US | $271K | 21K | 0.09 |
| Nurix Therapeutics, Inc. | Long | Equity-common | US | $207K | 9K | 0.07 |
| Nuvalent, Inc., Class A | Long | Equity-common | US | $397K | 5K | 0.13 |
| Ocular Therapeutix, Inc. | Long | Equity-common | US | $195K | 23K | 0.06 |
| OFG Bancorp | Long | Equity-common | PR | $4M | 82K | 1.17 |
| Old National Bancorp | Long | Equity-common | US | $5M | 240K | 1.52 |
| Pacira BioSciences, Inc. | Long | Equity-common | US | $145K | 7K | 0.05 |
| PBF Energy, Inc., Class A | Long | Equity-common | US | $4M | 94K | 1.22 |
| Portland General Electric Co. | Long | Equity-common | US | $5M | 99K | 1.48 |
| Prestige Consumer Healthcare, Inc. | Long | Equity-common | US | $566K | 8K | 0.18 |
| Progyny, Inc. | Long | Equity-common | US | $3M | 111K | 0.99 |
| Prosperity Bancshares, Inc. | Long | Equity-common | US | $4M | 50K | 1.15 |
| Protagonist Therapeutics, Inc. | Long | Equity-common | US | $352K | 9K | 0.11 |
| PTC Therapeutics, Inc. | Long | Equity-common | US | $407K | 12K | 0.13 |
| Ramaco Resources, Inc., Class A | Long | Equity-common | US | $4M | 323K | 1.39 |
| Recursion Pharmaceuticals, Inc., Class A | Long | Equity-common | US | $254K | 31K | 0.08 |
| Remitly Global, Inc. | Long | Equity-common | US | $5M | 343K | 1.44 |
| Repay Holdings Corp. | Long | Equity-common | US | $4M | 429K | 1.31 |
| REVOLUTION Medicines, Inc. | Long | Equity-common | US | $1M | 25K | 0.36 |
| Rhythm Pharmaceuticals, Inc. | Long | Equity-common | US | $399K | 8K | 0.13 |
| Rocket Pharmaceuticals, Inc. | Long | Equity-common | US | $257K | 11K | 0.08 |
| Ryder System, Inc. | Long | Equity-common | US | $5M | 39K | 1.71 |
| SEMrush Holdings, Inc., Class A | Long | Equity-common | US | $4M | 292K | 1.36 |
| Sensient Technologies Corp. | Long | Equity-common | US | $5M | 64K | 1.59 |
| Shift4 Payments, Inc., Class A | Long | Equity-common | US | $4M | 55K | 1.20 |
| SI-BONE, Inc. | Long | Equity-common | US | $3M | 166K | 0.80 |
| Skyline Champion Corp. | Long | Equity-common | US | $7M | 82K | 2.13 |
| SolarWinds Corp. | Long | Equity-common | US | $4M | 314K | 1.19 |
| Soleno Therapeutics, Inc. | Long | Equity-common | US | $163K | 3K | 0.05 |
| SpringWorks Therapeutics, Inc. | Long | Equity-common | US | $386K | 11K | 0.12 |
| Spyre Therapeutics, Inc. | Long | Equity-common | US | $158K | 6K | 0.05 |
| Stellar Bancorp, Inc. | Long | Equity-common | US | $3M | 125K | 1.08 |
| Supernus Pharmaceuticals, Inc. | Long | Equity-common | US | $234K | 8K | 0.07 |
| Syndax Pharmaceuticals, Inc. | Long | Equity-common | US | $300K | 13K | 0.10 |
| Taboola.com Ltd. | Long | Equity-common | IL | $4M | 1M | 1.31 |
| Tarsus Pharmaceuticals, Inc. | Long | Equity-common | US | $137K | 6K | 0.04 |
| TG Therapeutics, Inc. | Long | Equity-common | US | $430K | 22K | 0.14 |
| Tidewater, Inc. | Long | Equity-common | US | $5M | 49K | 1.52 |
| Tower Semiconductor Ltd. | Long | Equity-common | IL | $6M | 137K | 1.76 |
| TTM Technologies, Inc. | Long | Equity-common | US | $5M | 277K | 1.70 |
| Twist Bioscience Corp. | Long | Equity-common | US | $510K | 9K | 0.16 |
| United Community Banks, Inc. | Long | Equity-common | US | $3M | 111K | 1.09 |
| Vaxcyte, Inc. | Long | Equity-common | US | $1M | 18K | 0.45 |
| Vera Therapeutics, Inc. | Long | Equity-common | US | $232K | 6K | 0.07 |
| Veracyte, Inc. | Long | Equity-common | US | $289K | 12K | 0.09 |
| Vericel Corp. | Long | Equity-common | US | $372K | 7K | 0.12 |
| Verint Systems, Inc. | Long | Equity-common | US | $5M | 151K | 1.73 |
| Veritex Holdings, Inc. | Long | Equity-common | US | $3M | 136K | 1.08 |
| WSFS Financial Corp. | Long | Equity-common | US | $3M | 61K | 1.10 |
| Xencor, Inc. | Long | Equity-common | US | $192K | 9K | 0.06 |
| Xometry, Inc., Class A | Long | Equity-common | US | $4M | 246K | 1.14 |
Address
MAINSTAY FUNDS TRUST
51 MADISON AVE
NEW YORK
New York
10010
United States of America
Websites
Directors
Susan B. Kerley
Jacques P. Perold
Karen Hammond
Alan R. Latshaw
Richard S. Trutanic
Naim Abou-Jaoude
David H. Chow
Transfer Agents
SS&C Global Investor & Distribution Solutions, Inc.
NYLIM Service Company LLC
Pricing Services
ICE Data Pricing & Reference Data, LLC
Custodians
HSBC Bank Argentina S.A.
Banco Santander Chile
HSBC Bank (Vietnam) Ltd.
HSBC Bank Middle East Limited
Citibank A.S.
Euroclear
UniCredit Bank Czech Republic and Slovakia, a.s.
Banco Nacional de Mexico, S.A.
J.P. Morgan Bank Luxembourg S.A.
The Hongkong and Shanghai Banking Corporation Limited
HSBC Bank (China) Company Limited
Bank Handlowy w. Warszawie S.A.
HSBC Bank Malaysia Berhad
FirstRand Bank Limited
DBS Bank Ltd
Standard Chartered Bank Korea Limited
JPMorgan Chase Bank, N.A.
JPMorgan Chase Bank, N.A.
Royal Bank of Canada
JPMorgan Chase Bank, N.A.
Deutsche Bank AG
Cititrust Colombia S.A.
Citibank, N.A.
JPMorgan Chase Bank, N.A.
Citibank del Peru S.A.
Standard Chartered Bank Kenya Limited
J.P. Morgan Saudi Arabia Company
Standard Chartered Bank (Thai) Public Company Limited
The Hongkong and Shanghai Banking Corporation Limited
HSBC Bank Middle East Limited
JPMorgan Chase Bank, N.A.
HSBC France Athens Branch
J.P. Morgan Bank International (Limited Liability Company)**
PT Bank HSBC Indonesia
J.P. Morgan S.A. DTVM
Shareholder Servicing Agents
SS&C Global Investor & Distribution Solutions, Inc.
NYLIM Service Company LLC
Admins
JPMorgan Chase Bank, N.A.
New York Life Investment Management LLC
Brokers
Goldman Sachs & Co. LLC
Morgan Stanley & Co. LLC
Instinet, LLC
J.P. Morgan Securities LLC
Merrill Lynch, Pierce, Fenner & Smith Inc.
CLSA Americas, LLC
BofA Securities, Inc.
Citigroup Global Markets Inc.
Societe Generale
UBS Securities LLC